Shanghai Xuerong Bio-Technology Co Ltd
Shanghai Xuerong Biotechnology Co.,Ltd., together with its subsidiaries, engages in the research and development, cultivation and sale of fresh edible mushrooms in the People's Republic of China. It offers enoki mushrooms; shiitake mushrooms, including oyster mushrooms, white jade mushrooms and seafood mushrooms; king oyster mushrooms; and velvet mushrooms, as well as Pleurotus eryngii and Flammu… Read more
Shanghai Xuerong Bio-Technology Co Ltd (300511) - Net Assets
Latest net assets as of June 2025: CN¥1.17 Billion CNY
Based on the latest financial reports, Shanghai Xuerong Bio-Technology Co Ltd (300511) has net assets worth CN¥1.17 Billion CNY as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥3.61 Billion) and total liabilities (CN¥2.43 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.17 Billion |
| % of Total Assets | 32.53% |
| Annual Growth Rate | 6.63% |
| 5-Year Change | -59.3% |
| 10-Year Change | 28.05% |
| Growth Volatility | 32.54 |
Shanghai Xuerong Bio-Technology Co Ltd - Net Assets Trend (2012–2024)
This chart illustrates how Shanghai Xuerong Bio-Technology Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Shanghai Xuerong Bio-Technology Co Ltd (2012–2024)
The table below shows the annual net assets of Shanghai Xuerong Bio-Technology Co Ltd from 2012 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥823.32 Million | -42.52% |
| 2023-12-31 | CN¥1.43 Billion | -11.90% |
| 2022-12-31 | CN¥1.63 Billion | -1.74% |
| 2021-12-31 | CN¥1.65 Billion | -18.21% |
| 2020-12-31 | CN¥2.02 Billion | +16.26% |
| 2019-12-31 | CN¥1.74 Billion | +10.82% |
| 2018-12-31 | CN¥1.57 Billion | +10.84% |
| 2017-12-31 | CN¥1.42 Billion | +9.81% |
| 2016-12-31 | CN¥1.29 Billion | +100.60% |
| 2015-12-31 | CN¥642.99 Million | +21.55% |
| 2014-12-31 | CN¥529.00 Million | +22.03% |
| 2013-12-31 | CN¥433.49 Million | +13.73% |
| 2012-12-31 | CN¥381.15 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Shanghai Xuerong Bio-Technology Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 395.6% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CN¥1.40 Billion | 149.51% |
| Total Equity | CN¥938.63 Million | 100.00% |
Shanghai Xuerong Bio-Technology Co Ltd Competitors by Market Cap
The table below lists competitors of Shanghai Xuerong Bio-Technology Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
China Modern Dairy Holdings Ltd
F:07M
|
$503.81 Million |
|
Wuhan Huazhong Numerical Control Co Ltd
SHE:300161
|
$503.84 Million |
|
Atlantic China Welding Consumables Inc
SHG:600558
|
$503.90 Million |
|
Sagicor Financial Company Ltd
PINK:SGCFF
|
$503.92 Million |
|
NACHI-FUJIKOSHI
F:8UM
|
$503.77 Million |
|
INDUS Holding AG
PINK:INDHF
|
$503.74 Million |
|
DCB Bank Limited
NSE:DCBBANK
|
$503.70 Million |
|
China VTV Ltd
PINK:CVTV
|
$503.67 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shanghai Xuerong Bio-Technology Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,554,529,572 to 938,628,712, a change of -615,900,860 (-39.6%).
- Net loss of 617,070,813 reduced equity.
- Dividend payments of 67,006,895 reduced retained earnings.
- Other factors increased equity by 68,176,848.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-617.07 Million | -65.74% |
| Dividends Paid | CN¥67.01 Million | -7.14% |
| Other Changes | CN¥68.18 Million | +7.26% |
| Total Change | CN¥- | -39.62% |
Book Value vs Market Value Analysis
This analysis compares Shanghai Xuerong Bio-Technology Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.71x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 2.19x to 3.71x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | CN¥3.19 | CN¥6.98 | x |
| 2018-12-31 | CN¥3.61 | CN¥6.98 | x |
| 2019-12-31 | CN¥4.05 | CN¥6.98 | x |
| 2020-12-31 | CN¥4.60 | CN¥6.98 | x |
| 2021-12-31 | CN¥3.78 | CN¥6.98 | x |
| 2022-12-31 | CN¥3.47 | CN¥6.98 | x |
| 2023-12-31 | CN¥3.12 | CN¥6.98 | x |
| 2024-12-31 | CN¥1.88 | CN¥6.98 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shanghai Xuerong Bio-Technology Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -65.74%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -28.54%
- • Asset Turnover: 0.56x
- • Equity Multiplier: 4.11x
- Recent ROE (-65.74%) is below the historical average (-4.19%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 19.43% | 12.10% | 0.57x | 2.80x | CN¥59.86 Million |
| 2016 | 8.17% | 10.49% | 0.41x | 1.92x | CN¥-23.42 Million |
| 2017 | 8.82% | 9.20% | 0.35x | 2.77x | CN¥-16.31 Million |
| 2018 | 9.65% | 8.20% | 0.47x | 2.48x | CN¥-5.43 Million |
| 2019 | 12.66% | 11.22% | 0.51x | 2.21x | CN¥46.28 Million |
| 2020 | 12.16% | 11.23% | 0.48x | 2.24x | CN¥43.84 Million |
| 2021 | -18.47% | -14.97% | 0.48x | 2.60x | CN¥-476.11 Million |
| 2022 | -16.48% | -12.38% | 0.57x | 2.34x | CN¥-461.55 Million |
| 2023 | -12.10% | -7.33% | 0.56x | 2.96x | CN¥-343.52 Million |
| 2024 | -65.74% | -28.54% | 0.56x | 4.11x | CN¥-710.93 Million |
Industry Comparison
This section compares Shanghai Xuerong Bio-Technology Co Ltd's net assets metrics with peer companies in the Farm Products industry.
Industry Context
- Industry: Farm Products
- Average net assets among peers: $1,314,559,364
- Average return on equity (ROE) among peers: 7.02%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shanghai Xuerong Bio-Technology Co Ltd (300511) | CN¥1.17 Billion | 19.43% | 2.07x | $503.80 Million |
| ShenZhen Kondarl Group Co Ltd (000048) | $493.88 Million | 5.67% | 1.45x | $677.04 Million |
| Hunan Zhenghong Science and Technology Develop Co Ltd (000702) | $473.86 Million | 3.40% | 0.49x | $192.35 Million |
| Hefei Fengle Seed Co Ltd (000713) | $541.01 Million | 5.38% | 1.28x | $460.52 Million |
| Luoniushan Co Ltd (000735) | $1.57 Billion | 5.18% | 0.35x | $939.65 Million |
| New Hope Liuhe Co Ltd (000876) | $4.62 Billion | 8.84% | 0.83x | $3.80 Billion |
| Yuan Longping High-tech Agriculture Co Ltd (000998) | $903.81 Million | 2.44% | 0.22x | $1.92 Billion |
| Dongrui Food Group Co Ltd (001201) | $326.81 Million | 2.47% | 0.90x | $262.05 Million |
| Jiangxi Sunshine Dairy Co Ltd (001318) | $555.07 Million | 18.79% | 0.29x | $164.61 Million |
| Boen Group Co. Ltd. Cl A (001366) | $521.42 Million | 14.80% | 0.42x | $88.79 Million |
| Shandong Denghai Seeds Co Ltd (002041) | $3.14 Billion | 3.25% | 0.20x | $542.58 Million |